---
$id: https://graph.org.ai/products/commodity/51281617
$type: Product
source: UNSPSC
code: "51281617"
title: "Micronomicin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Micronomicin

**UNSPSC Code**: 51281617
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C20H41N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S9AZ0R40QV, chemically known as o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-a-d-erythro-hexopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6))-2-deoxy-d-streptamine but generally known as micronomicin, which bears US NIH Compound Identifier 107677. European Medicines Agency schedules Micronomicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08945MIG. The term MICRONOMICIN is an International Non-Proprietary Name. World Health Organization schedules micronomicin in its Anatomical Therapeutic Chemical (ATC) Classification. MICRONOMICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule micronomicin under HS 29419000 and SITC 54139. As of Q4 2014, MICRONOMICIN remains the US FDA Preferred Term for this commodity. Micronomicin bears US NLM identifiers UMLS ID C0066520 and NCI Concept Code C90638. SMILES: O(C1C(O)C(OC2OC(CCC2N)CNC)C(N)CC1N)C1OCC(O)(C(NC)C1O)C.

